Culture of CAR T cells with IL-7 and IL-15 during manufacturing has been shown to enhance T cell differentiation toward a central memory (Tcm) phenotype, enhancing the persistence and anti-tumor efficacy of CAR T cells in vivo and prolonging survival in murine models of B-ALL29. Here, IL7 is linked to neoplasm.